Translate Bio, Inc.
(NASDAQ : TBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.14%178.091.3%$463.40m
CELGCelgene Corporation
0.90%97.381.3%$421.89m
GILDGilead Sciences, Inc.
1.27%67.210.9%$393.48m
BIIBBiogen Inc.
2.17%232.601.3%$355.06m
ILMNIllumina, Inc.
1.85%350.373.5%$272.91m
REGNRegeneron Pharmaceuticals, Inc.
1.98%311.292.6%$233.52m
AAgilent Technologies, Inc.
0.72%70.471.6%$213.59m
VRTXVertex Pharmaceuticals Incorporated
2.19%173.941.9%$198.43m
ARRYArray BioPharma Inc.
56.42%46.298.2%$185.45m
EXASExact Sciences Corporation
0.96%110.8325.3%$184.63m
ALXNAlexion Pharmaceuticals, Inc.
2.27%120.612.0%$176.07m
BMRNBioMarin Pharmaceutical Inc.
4.16%84.204.3%$136.24m
MRTXMirati Therapeutics Inc.
6.33%100.232.5%$113.79m
IONSIonis Pharmaceuticals, Inc.
4.43%64.848.2%$97.22m
INCYIncyte Corporation
5.44%81.942.5%$92.05m

Company Profile

Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidates include MRT5005 for the treatment of cystic fibrosis; and for the treatment of ornithine transcarbamylase deficiency. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA.